Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats

Parathyroid hormone (PTH) is an effective bone anabolic agent, but it must be administered parenterally. An orally active anabolic agent would provide a valuable alternative for treating osteoporosis. NPS 2143 is a novel, selective antagonist (a “calcilytic”) of the parathyroid cell Ca(2+) receptor....

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Gowen, Maxine, Stroup, George B., Dodds, Robert A., James, Ian E., Votta, Bart J., Smith, Brian R., Bhatnagar, Pradip K., Lago, Amparo M., Callahan, James F., DelMar, Eric G., Miller, Michael A., Nemeth, Edward F., Fox, John
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 2000
Soggetti:	Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC300853/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10841518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI9038
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!